1. Home
  2. CMPS vs CADL Comparison

CMPS vs CADL Comparison

Compare CMPS & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$6.78

Market Cap

598.7M

Sector

Health Care

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$6.35

Market Cap

339.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPS
CADL
Founded
2020
1999
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
598.7M
339.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
CMPS
CADL
Price
$6.78
$6.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$16.43
$19.43
AVG Volume (30 Days)
1.6M
936.0K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$4.25
52 Week High
$7.13
$13.68

Technical Indicators

Market Signals
Indicator
CMPS
CADL
Relative Strength Index (RSI) 66.43 72.12
Support Level $4.90 $5.39
Resistance Level $5.57 $6.83
Average True Range (ATR) 0.38 0.36
MACD 0.20 0.22
Stochastic Oscillator 84.53 80.81

Price Performance

Historical Comparison
CMPS
CADL

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: